Table 1. Characteristics of study population.
Variable | Value | Male (N = 1453) | Female (N = 1310) | Study Sample (N = 2763) | Excluded (N = 4051) |
Age | Mean +/− SD | 61.1+/−10.0 | 61.5+/− 10.1 | 61.3+/−10.0 | 62.7+/−10.3 |
Sex | Male | 1,453 (52.6) | 1,760 (43.4) | ||
Race | Caucasian | 576 (39.6) | 524 (40.0) | 1,100 (39.8) | 1,522 (37.6) |
Asian | 212 (14.6) | 202 (15.4) | 414 (15.0) | 389 (9.6) | |
African American | 339 (23.3) | 313 (23.9) | 652 (23.6) | 1,241 (30.6) | |
Hispanic | 326 (22.4) | 271 (20.7) | 597 (21.6) | 899 (22.2) | |
Education Level | < High School | 201 (13.8) | 217 (16.6) | 418 (15.1) | 807 (20.0) |
High School/GED | 219 (15.1) | 275 (21.0) | 494 (17.9) | 742 (18.4) | |
< College (> High School) | 364 (25.1) | 376 (28.7) | 740 (26.8) | 1,197 (29.7) | |
Bachelor's Degree | 303 (20.9) | 237 (18.1) | 540 (19.5) | 631 (15.7) | |
Graduate Degree | 366 (25.2) | 205 (15.6) | 571 (20.7) | 651 (16.2) | |
BMI | Mean +/− SD | 27.3+/−4.0 | 26.9+/−5.0 | 27.1+/−4.5 | 29.3+/−6.0 |
Waist Size (cm) | Mean +/− SD | 96.7+/−11.1 | 92.2+/−13.6 | 94.6+/−12.6 | 100.3+/−15.4 |
Hip Size (cm) | Mean +/− SD | 101.8+/−8.2 | 103.4+/−10.5 | 102.6+/−9.4 | 107.0+/−12.8 |
Total Intentional Exercise (MET-min per week) | Mean +/− SD | 1743.2+/−2235.4 | 1379.6+/−2405.9 | 1570.8+/−2324.5 | 1270.9+/−1996.8 |
Diabetes mellitus | Normal (<100 mg/dl) | 1,010 (69.5) | 1,012 (77.3) | 2,022 (73.2) | 2,616 (64.7) |
Impaired Fasting Glucose (100–125 mg/dl) | 248 (17.1) | 172 (13.1) | 420 (15.2) | 721 (17.8) | |
Untreated Diabetes (> = 126 mg/dl) | 45 (3.1) | 20 (1.5) | 65 (2.4) | 123 (3.0) | |
Treated Diabetes | 150 (10.3) | 106 (8.1) | 256 (9.3) | 582 (14.4) | |
Fasting Glucose (mg/dL)– Calibrated | Mean +/− SD | 100.3+/−27.2 | 94.1+/−21.5 | 97.4+/−24.9 | 102.5+/−34.0 |
Hypertension | Yes | 589 (40.5) | 536 (40.9) | 1,125 (40.7) | 2,053 (50.7) |
Systolic Blood Pressure (mmHg) | Mean +/− SD | 122.7+/−18.1 | 121.9+/−21.6 | 122.3+/−19.9 | 126.8+/−22.0 |
Diastolic Blood Pressure (mmHg) | Mean +/− SD | 73.4+/−9.0 | 67.2+/−9.7 | 70.5+/−9.8 | 70.7+/−10.4 |
Use of Anti-Hypertensives | Yes | 532 (36.6) | 474 (36.2) | 1,006 (36.4) | 1,838 (45.4) |
Total Cholesterol (mg/dl) | Mean +/− SD | 185.4+/−34.0 | 199.3+/−33.7 | 191.9+/−34.5 | 191.4+/−36.9 |
HDL Cholesterol (mg/dl) | Mean +/− SD | 46.7+/−12.3 | 58.6+/−16.0 | 52.3+/−15.3 | 51.3+/−14.9 |
LDL Cholesterol (mg/dl) | Mean +/− SD | 112.9+/−31.4 | 115.9+/−30.7 | 114.3+/−31.1 | 113.6+/−33.1 |
Triglycerides (mg/dl) | Mean +/− SD | 132.5+/−86.9 | 124.3+/−71.9 | 128.6+/−80.3 | 134.0+/−85.9 |
Statin Use | Yes | 194 (13.4) | 186 (14.2) | 380 (13.8) | 629 (15.5) |
Creatinine (mg/dl) | Mean +/− SD | 1.1+/−0.2 | 0.8+/−0.1 | 1.0+/−0.2 | 1.0+/−0.3 |
Interleukin-6 (IL-6) (pg/mL) | Mean +/− SD | 1.3+/−1.1 | 1.4+/−1.1 | 1.4+/−1.1 | 1.7+/−1.3 |
Smoking Status | Never | 582 (40.1) | 802 (61.2) | 1,384 (50.1) | 1,788 (44.2) |
Former | 730 (50.2) | 392 (29.9) | 1,122 (40.6) | 1,712 (42.3) | |
Current | 141 (9.7) | 116 (8.9) | 257 (9.3) | 546 (13.5) | |
Pack Years | Mean +/− SD | 12.2+/−22.5 | 5.9+/−13.4 | 9.2+/−19.0 | 12.9+/−24.1 |